Comparative studies targeting CRC isolated from patients with ccRCC and from patients with benign kidney diseases, including patients affected by hereditary VHL disease at the pre-cancerous stage, could also help to assess the diagnostic value of specifically targeted DNA mutations, including VHL mutations. The gene discussed is VHL; the disease is colorectal carcinoma.